Skip to main content
OpenTrials

Clinical trial condition

Idiopathic Pulmonary Fibrosis

Explore clinical trials studying Idiopathic Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

436 public trials 71 recruiting studies
Refine in advanced search Browse all conditions

Idiopathic Pulmonary Fibrosis trial results

Completed

Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

NCT05255991

Conditions
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Lung Diseases, +3 more
Locations
  • CINME S.A. - Centro de Investigaciones Metabolicas Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • Centro Medico Dra. De Salvo Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • Instituto Ave Pulmo - Fundación enfisema Mar del Plata, Buenos Aires, Argentina
  • Sanatorio Allende S.A. Córdoba, Córdoba Province, Argentina
View all 108 locations
View Trial Details
Completed

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibody (mAb) in Patients With IPF (SAD).

NCT05513950

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • PHI University Clinic of Pulmonology and Allergology Skopje, North Macedonia
  • Medical Center of Limited Liability Company "Arensia Exploratory Medicine", department of Clinical Trials Kyiv, Ukraine
  • Queen Elizabeth Hospital - NIHR Birmingham Clinical Research Facility - University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • Royal Papworth Hospital NHSFT - Cambridge Biomedical Campus Cambridge, United Kingdom
View Trial Details
Completed

A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients

NCT05954988

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Agaplesion Evangelisches Krankenhaus Mittelhessen Giessen, Germany
View Trial Details
Completed

Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT

NCT02036970

Conditions
Acute Interstitial Pneumonitis, Bronchial Diseases, Bronchiolitis, +32 more
Locations
  • Banner University Medical Center, Phoenix Advanced Lung Disease Institute Phoenix, Arizona, United States
  • Arizona Pulmonary Specialists Phoenix, Arizona, United States
  • Cedars Sinai Medical Center Beverly Hills, California, United States
  • VA Healthcare System of Greater Los Angeles Los Angeles, California, United States
View all 32 locations
View Trial Details
Completed

Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF

NCT04533022

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • AMCMET Medical College and Sheth LG General Hospital Ahmedabad, Gujarat, India
  • Unity Hospital Surat, Gujarat, India
  • The Bhatia Hospital Mumbai, Maharashtra, India
  • Grant Government Medical Collage and Sir J.J. Group of Hospitals Mumbai, Maharashtra, India
View all 21 locations
View Trial Details

Related conditions